Dolasetron
- Level
- Commodity
- Parent
- 51171800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171814This classification denotes a 5-ht3 receptor antagonist and antiemetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 82WI2L7Q6E. European Medicines Agency schedules Dolasetron in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06352MIG. Dolasetron generally arises in the molecular formula C19H20N2O3. The term DOLASETRON is an International Non-Proprietary Name or INN. DOLASETRON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dolasetron under HS 29339990 and SITC 51577. As of Q4 2014, DOLASETRON remains the US FDA Preferred Term for this commodity. Dolasetron bears US NLM identifiers UMLS ID C0209210 and NCI Concept Code C61735. SMILES: O(C1CC2N3C(CC(C2)C(=O)C3)C1)C(=O)C1C2C([NH]C1)CCCC2.
Same parent
Under 51171800 · 49Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.